2021
DOI: 10.1111/apm.13198
|View full text |Cite
|
Sign up to set email alerts
|

Weight‐based cefuroxime dosing provides comparable orthopedic target tissue concentrations between weight groups – a microdialysis porcine study

Abstract: Antibiotic prophylaxis is a key element in prevention of surgical site infections. For the majority of orthopedic procedures, antibiotic administration follows fixed dosing regimens irrespective of weight. However, this may result in insufficient antibiotic target tissue concentrations and higher risk of surgical site infections in obese individuals. The aim of this study was to investigate the effect of weight‐based cefuroxime dosing on plasma and target tissue concentrations. Eighteen female pigs were alloca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 38 publications
(44 reference statements)
0
4
0
Order By: Relevance
“…The intermediate precision for the internal controls at four levels, determined over 43 runs, for cefuroxime was 14.2% (target 0.010 μg·ml −1 ), 9.6% (target 0.050 μg·ml −1 ), 2.6% (target 5.00 μg·ml −1 ), and 3.9% (target 10.00 μg·ml −1 ), whereas it was 16.6% (target 0.050 μg·ml −1 ), 3.9% (target 5.00 μg ml −1 ), and 5.6% (target 10.00 μg·ml −1 ) for meropenem at three levels, determined over 36 runs. The chemical analysis has previously been applied in studies examining cefuroxime concentrations (Hvistendahl, Bue, et al, 2022; Tøstesen et al, 2022).…”
Section: Methodsmentioning
confidence: 99%
“…The intermediate precision for the internal controls at four levels, determined over 43 runs, for cefuroxime was 14.2% (target 0.010 μg·ml −1 ), 9.6% (target 0.050 μg·ml −1 ), 2.6% (target 5.00 μg·ml −1 ), and 3.9% (target 10.00 μg·ml −1 ), whereas it was 16.6% (target 0.050 μg·ml −1 ), 3.9% (target 5.00 μg ml −1 ), and 5.6% (target 10.00 μg·ml −1 ) for meropenem at three levels, determined over 36 runs. The chemical analysis has previously been applied in studies examining cefuroxime concentrations (Hvistendahl, Bue, et al, 2022; Tøstesen et al, 2022).…”
Section: Methodsmentioning
confidence: 99%
“…Laboratory analyses were utilised at the Department of Clinical Biochemistry, Lillebaelt Hospital Vejle, Denmark. Adhering to recommendations of Replacement, Reduction or Refinement in animal studies [ 36 ], the same 18 pigs were included in a study investigating the effect of weight-based cefuroxime dosing on orthopaedic relevant target tissue concentrations in the first dosing interval [ 37 ].…”
Section: Methodsmentioning
confidence: 99%
“…The free unbound concentrations of cefuroxime in plasma and dialysates and meropenem in dialysates were quantified using a validated LC-MS/MS assay [ 37 ]. For cefuroxime the inter-run imprecisions were 14.2% at 0.01 µg/mL, 9.6% at 0.05 µg/mL, 2.6% at 5.00 µg/mL and 3.9% at 10.00 µg/mL.…”
Section: Methodsmentioning
confidence: 99%
“…Cefuroxime, a second-generation cephalosporin with few side effects, is widely used for perioperative antibiotic prophylaxis in spine surgery, as its antimicrobial spectrum covers the most frequent bacteria causing infection after spine surgery ( 7 , 8 ). The pharmacokinetic tool, microdialysis, allows for dynamic real-time perioperative sampling of the unbound fraction of cefuroxime and has the potential to estimate perioperative proximate implant concentrations ( 9 , 10 ). We compared the perioperative concentrations of cefuroxime inside a cannulated pedicle screw with the opposite non-instrumented vertebral pedicle using microdialysis, following a single-dose intravenous cefuroxime administration of 1.5 g. We hypothesized that introduction of a commonly applied cannulated pedicle screw induces subtherapeutic perioperative proximate internal implant concentrations.…”
mentioning
confidence: 99%